452 related articles for article (PubMed ID: 17174192)
1. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
Germans T; Wilde AA; Dijkmans PA; Chai W; Kamp O; Pinto YM; van Rossum AC
J Am Coll Cardiol; 2006 Dec; 48(12):2518-23. PubMed ID: 17174192
[TBL] [Abstract][Full Text] [Related]
2. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
4. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
5. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy.
Satoh H; Matoh F; Shiraki K; Saitoh T; Odagiri K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2009 Jun; 15(5):419-27. PubMed ID: 19477402
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects.
Konno T; Shimizu M; Ino H; Fujino N; Hayashi K; Uchiyama K; Kaneda T; Inoue M; Masuda E; Mabuchi H
J Intern Med; 2005 Sep; 258(3):216-24. PubMed ID: 16115294
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
9. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
[TBL] [Abstract][Full Text] [Related]
10. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
Timmer SA; Germans T; Brouwer WP; Lubberink M; van der Velden J; Wilde AA; Christiaans I; Lammertsma AA; Knaapen P; van Rossum AC
Eur J Heart Fail; 2011 Dec; 13(12):1283-9. PubMed ID: 22021246
[TBL] [Abstract][Full Text] [Related]
11. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study.
Delcrè SD; Di Donna P; Leuzzi S; Miceli S; Bisi M; Scaglione M; Caponi D; Conte MR; Cecchi F; Olivotto I; Gaita F
Int J Cardiol; 2013 Aug; 167(3):1038-45. PubMed ID: 22464482
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and hypertrophic segments distribution of patients with hypertrophic cardiomyopathy].
YAN CW; ZHAO SH; LI H; JIANG SL; LU MJ; ZHANG Y; WEI YQ; LING J; FANG W
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):781-5. PubMed ID: 21092643
[TBL] [Abstract][Full Text] [Related]
13. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
[TBL] [Abstract][Full Text] [Related]
14. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
[TBL] [Abstract][Full Text] [Related]
15. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
[TBL] [Abstract][Full Text] [Related]
17. [Cardiomyopathy and sport].
Hagège A
Arch Mal Coeur Vaiss; 2006 Nov; 99(11):1007-10. PubMed ID: 17181041
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
19. A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy.
Hirota T; Kubo T; Kitaoka H; Hamada T; Baba Y; Hayato K; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Doi YL
J Cardiol; 2010 Jul; 56(1):59-65. PubMed ID: 20350521
[TBL] [Abstract][Full Text] [Related]
20. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
Pujadas S; Vidal-Perez R; Hidalgo A; Leta R; Carreras F; Barros A; Bayes-Genis A; Subirana MT; Pons-Llado G
Eur J Radiol; 2010 Aug; 75(2):e88-91. PubMed ID: 20079992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
